What were Viyash Scientific Ltd's latest quarterly results?
Viyash Scientific Ltd's latest quarterly results (Dec 2025) show
- PAT Growth YoY: +16.7%
- Revenue Growth YoY: +10.9%
- Operating Margin: 20.0%
Viyash Scientific Ltd (Pharma - Animal) — fundamental analysis, earnings data, and key metrics. PE: 64.1. ROE: 3.2%. This stock is not currently in the Nifty 500 momentum outperformers list.
Based on publicly available financial data. This is educational research, not investment advice.
Viyash Scientific Ltd's latest quarterly results (Dec 2025) show
Viyash Scientific Ltd's current PE ratio is 64.1x.
Viyash Scientific Ltd's price-to-book ratio is 10.1x.
Viyash Scientific Ltd's fundamental strength based on key financial ratios
Viyash Scientific Ltd has a debt-to-equity ratio of N/A.
Viyash Scientific Ltd's return ratios over recent years
Viyash Scientific Ltd's operating cash flow is positive (FY2025).
Viyash Scientific Ltd currently does not pay a significant dividend (yield 0.00%).
Viyash Scientific Ltd's shareholding pattern (Dec 2025)
Viyash Scientific Ltd's promoter holding has increased recently.
Viyash Scientific Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Based on quantitative research signals, here is why Viyash Scientific Ltd may be worth studying
Viyash Scientific Ltd investment thesis summary:
Viyash Scientific Ltd's forward outlook based on current data signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.